Design Therapeutics (DSGN) Operating Expenses (2020)
Historic Operating Expenses for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to $3.9 million.
- Design Therapeutics' Operating Expenses changed N/A to $3.9 million in Q4 2020 from the same period last year, while for Sep 2021 it was $3.9 million, marking a year-over-year change of. This contributed to the annual value of $8.6 million for FY2020, which is N/A changed from last year.
- According to the latest figures from Q4 2020, Design Therapeutics' Operating Expenses is $3.9 million.
- Design Therapeutics' Operating Expenses' 5-year high stood at $3.9 million during Q4 2020, with a 5-year trough of $765000.0 in Q1 2020.